RPMGX
Price
$103.49
Change
+$0.28 (+0.27%)
Updated
Sep 8 closing price
Net Assets
27.36B
VAKSX
Price
$11.29
Change
+$0.05 (+0.44%)
Updated
Sep 8 closing price
Net Assets
7.74M
Interact to see
Advertisement

RPMGX vs VAKSX

Header iconRPMGX vs VAKSX Comparison
Open Charts RPMGX vs VAKSXBanner chart's image
T. Rowe Price Mid-Cap Growth
Price$103.49
Change+$0.28 (+0.27%)
VolumeN/A
Net Assets27.36B
Virtus KAR Small-Mid Cap Growth A
Price$11.29
Change+$0.05 (+0.44%)
VolumeN/A
Net Assets7.74M
RPMGX vs VAKSX Comparison Chart in %
Loading...
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 27.4B vs. VAKSX (7.74M). RPMGX (0.00) and VAKSX (0.00) have matching dividends . RPMGX was incepted earlier than VAKSX: RPMGX (33 years) vs VAKSX (5 years). VAKSX (2.12) is less costly to investors than RPMGX (0.75). VAKSX is a more actively managed with annual turnover of: 37.00 vs. RPMGX (22.60). RPMGX (2500) and VAKSX (2500) have matching initial minimum investment requirements. VAKSX annual gain was more profitable for investors over the last year : 8.14 vs. RPMGX (-0.88).
RPMGXVAKSXRPMGX / VAKSX
Total Expense Ratio0.751.3058%
Annual Report Gross Expense Ratio0.752.1235%
Fund Existence33 years5 years-
Gain YTD3.7702.264166%
Front LoadN/A6%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets27.4B7.74M354,051%
Annual Yield % from dividends0.000.00-
Returns for 1 year-0.888.14-11%
Returns for 3 years8.9232.2028%
Returns for 5 years3.60N/A-
Returns for 10 years30.38N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIOVF29.18N/A
N/A
Swedish Orphan Biovitrum AB
PRTT0.35N/A
N/A
Protect Pharmaceutical Corp
NICMF0.46N/A
N/A
Nickel Industries Ltd
KSHOF9.53N/A
N/A
K S Holdings Corporation
UBAB55.20-0.54
-0.97%
United Bancorporation of Alabama, Inc.